Treadmill running upregulates the expression of acetylcholine receptor in rat gastrocnemius following botulinum toxin A injection

Journal of Orthopaedic Research

Volumn 31, Issue 1, 2013, Pages 125-131

  Tsai, Sen Wei ^a,b,c   Tung, Yu Tang ^a   Chen, Hsiao Ling ^d   Shen, Chih Jie ^a   Chuang, Chia Hui ^a   Tang, Ting Yu ^a   Chen, Chuan Mu ^a,e  

^a NATIONAL CHUNG HSING UNIVERSITY   (Taiwan)

^b TAICHUNG VETERANS GENERAL HOSPITAL   (Taiwan)

^c NATIONAL YANG MING UNIVERSITY   (Taiwan)

^d DA YEH UNIVERSITY   (Taiwan)

^e CHINA MEDICAL UNIVERSITY   (Taiwan)

Author keywords

acetylcholine receptor; botulinum toxin; neuromuscular junction; treadmill

Indexed keywords

BOTULINUM TOXIN A; CHOLINERGIC RECEPTOR; CHOLINERGIC RECEPTOR ALPHA; CHOLINERGIC RECEPTOR BETA; CHOLINERGIC RECEPTOR EPSILON; CHOLINERGIC RECEPTOR GAMMA; GAP43 PROTEIN; MRF4 PROTEIN; MYOD PROTEIN; MYOGENIC FACTOR 5; MYOGENIN; PROTEIN P21; SOMATOMEDIN C; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ARTICLE; BODY MASS; CONTROLLED STUDY; GASTROCNEMIUS MUSCLE; GENE EXPRESSION; MALE; MUSCLE CONTRACTION; MUSCLE DEVELOPMENT; MUSCLE MASS; MUSCLE STRENGTH; NERVE CELL PLASTICITY; NEUROMUSCULAR SYNAPSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN ANALYSIS; RAT; RUNNING; TREADMILL; UPREGULATION;

ANIMALS; BOTULINUM TOXINS, TYPE A; EXERCISE TEST; GENE EXPRESSION; MALE; MUSCLE CONTRACTION; MUSCLE PROTEINS; MUSCLE, SKELETAL; NEUROMUSCULAR AGENTS; NEUROMUSCULAR JUNCTION; PROTEIN SUBUNITS; RATS; RATS, SPRAGUE-DAWLEY; RECEPTORS, NICOTINIC; RUNNING; UP-REGULATION;

EID: 84870242348     PISSN: 07360266     EISSN: 1554527X     Source Type: Journal    
DOI: 10.1002/jor.22180     Document Type: Article

References (47)

1. Stoquart GG, Detrembleur C, Palumbo S, et al. 2008. Effect of botulinum toxin injection in the rectus femoris on stiff-knee gait in people with stroke: a prospective observational study. Arch Phys Med Rehabil 89: 56-61.
2. Lannin N, Scheinberg A, Clark K., 2006. AACPDM systematic review of the effectiveness of therapy for children with cerebral palsy after botulinum toxin A injections. Dev Med Child Neurol 48: 533-539.
3. Baricich A, Carda S, Bertoni M, et al. 2008. A single-blinded, randomized pilot study of botulinum toxin type A combined with non-pharmacological treatment for spastic foot. J Rehabil Med 40: 870-872.
4. Eleopra R, Tugnoli V, Rossetto O, et al. 1998. Different time courses of recovery after poisoning with botulinum neurotoxin serotypes A and E in humans. Neurosci Lett 256: 135-138.
5. Pandyan AD, Vuadens P, van Wijck FM, et al. 2002. Are we underestimating the clinical efficacy of botulinum toxin (type A)? Quantifying changes in spasticity, strength and upper limb function after injections of Botox to the elbow flexors in a unilateral stroke population. Clin Rehabil 16: 654-660.
6. de Paiva A, Meunier FA, Molgo J, et al. 1999. Functional repair of motor endplates after botulinum neurotoxin type A poisoning: biphasic switch of synaptic activity between nerve sprouts and their parent terminals. Proc Natl Acad Sci USA 96: 3200-3205.
7. Rogozhin AA, Pang KK, Bukharaeva E, et al. 2008. Recovery of mouse neuromuscular junctions from single and repeated injections of botulinum neurotoxin A. J Physiol 586: 3163-3182.
8. Frasson E, Priori A, Ruzzante B, et al. 2005. Nerve stimulation boosts botulinum toxin action in spasticity. Mov Disord 20: 624-629.
9. Kim HS, Hwang JH, Jeong ST, et al. 2003. Effect of muscle activity and botulinum toxin dilution volume on muscle paralysis. Dev Med Child Neurol 45: 200-206.
10. Liu M, Stevens-Lapsley JE, Jayaraman A, et al. 2010. Impact of treadmill locomotor training on skeletal muscle IGF1 and myogenic regulatory factors in spinal cord injured rats. Eur J Appl Physiol 109: 709-720.
11. Brown DA, Johnson MS, Armstrong CJ, et al. 2007. Short-term treadmill running in the rat: what kind of stressor is it ? J Appl Physiol 103: 1979-1985.
12. Dobkin BH, Apple D, Barbeau H, et al. 2003. Methods for a randomized trial of weight-supported treadmill training versus conventional training for walking during inpatient rehabilitation after incomplete traumatic spinal cord injury. Neurorehabil Neural Repair 17: 153-167.
13. Mattern-Baxter K, Bellamy S, Mansoor JK., 2009. Effects of intensive locomotor treadmill training on young children with cerebral palsy. Pediatr Phys Ther 21: 308-318.
14. Borggraefe I, Schaefer JS, Klaiber M, et al. 2010. Robotic-assisted treadmill therapy improves walking and standing performance in children and adolescents with cerebral palsy. Eur J Paediatr Neurol 14: 496-502.
15. Willoughby KL, Dodd KJ, Shields N., 2009. A systematic review of the effectiveness of treadmill training for children with cerebral palsy. Disabil Rehabil 31: 1971-1979.
16. Borggraefe I, Meyer-Heim A, Kumar A, et al. 2008. Improved gait parameters after robotic-assisted locomotor treadmill therapy in a 6-year-old child with cerebral palsy. Mov Disord 23: 280-283.
17. Cherng RJ, Liu CF, Lau TW, et al. 2007. Effect of treadmill training with body weight support on gait and gross motor function in children with spastic cerebral palsy. Am J Phys Med Rehabil 86: 548-555.
18. Mutlu A, Krosschell K, Spira DG., 2009. Treadmill training with partial body-weight support in children with cerebral palsy: a systematic review. Dev Med Child Neurol 51: 268-275.
19. Hodapp M, Vry J, Mall V, et al. 2009. Changes in soleus H-reflex modulation after treadmill training in children with cerebral palsy. Brain 132: 37-44.
20. Marcuzzo S, Dutra MF, Stigger F, et al. 2008. Beneficial effects of treadmill training in a cerebral palsy-like rodent model: walking pattern and soleus quantitative histology. Brain Res 1222: 129-140.
21. Velders M, Legerlotz K, Falconer SJ, et al. 2008. Effect of botulinum toxin A-induced paralysis and exercise training on mechanosensing and signalling gene expression in juvenile rat gastrocnemius muscle. Exp Physiol 93: 1273-1283.
22. Tsai SW, Chen CJ, Chen HL, et al. 2012. Effects of treadmill running on rat gastrocnemius function following botulinum toxin A injection. J Orthop Res 30: 319-324.
23. McPherron AC, Lawler AM, Lee SJ., 1997. Regulation of skeletal muscle mass in mice by a new TGF-beta superfamily member. Nature 387: 83-90.
24. Schuelke M, Wagner KR, Stolz LE, et al. 2004. Myostatin mutation associated with gross muscle hypertrophy in a child. N Engl J Med 350: 2682-2688.
25. Williams MS., 2004. Myostatin mutation associated with gross muscle hypertrophy in a child. N Engl J Med 351: 1030-1031 (author reply 1030-1031).
26. Hawke TJ, Meeson AP, Jiang N, et al. 2003. p21 is essential for normal myogenic progenitor cell function in regenerating skeletal muscle. Am J Physiol Cell Physiol 285: C1019-C1027.
27. Rios R, Carneiro I, Arce VM, et al. 2001. Myostatin regulates cell survival during C2C12 myogenesis. Biochem Biophys Res Commun 280: 561-566.
28. Parker SB, Eichele G, Zhang P, et al. 1995. p53-independent expression of p21Cip1 in muscle and other terminally differentiating cells. Science 267: 1024-1027.
29. Mok GF, Sweetman D., 2011. Many routes to the same destination: lessons from skeletal muscle development. Reproduction 141: 301-312.
30. Ma J, Shen J, Lee CA, et al. 2005. Gene expression of nAChR, SNAP-25 and GAP-43 in skeletal muscles following botulinum toxin A injection: a study in rats. J Orthop Res 23: 302-309.
31. Shen J, Ma J, Lee C, et al. 2006. How muscles recover from paresis and atrophy after intramuscular injection of botulinum toxin A: study in juvenile rats. J Orthop Res 24: 1128-1135.
32. Holland RL, Brown MC., 1980. Postsynaptic transmission block can cause terminal sprouting of a motor nerve. Science 207: 649-651.
33. Hansson HA, Dahlin LB, Danielsen N, et al. 1986. Evidence indicating trophic importance of IGF-I in regenerating peripheral nerves. Acta Physiol Scand 126: 609-614.
34. Rabinovsky ED, Gelir E, Gelir S, et al. 2003. Targeted expression of IGF-1 transgene to skeletal muscle accelerates muscle and motor neuron regeneration. FASEB J 17: 53-55.
35. Chakravarthy MV, Abraha TW, Schwartz RJ, et al. 2000. Insulin-like growth factor-I extends in vitro replicative life span of skeletal muscle satellite cells by enhancing G1/S cell cycle progression via the activation of phosphatidylinositol 3'-kinase/Akt signaling pathway. J Biol Chem 275: 35942-35952.
36. McKay BR, O'Reilly CE, Phillips SM, et al. 2008. Co-expression of IGF-1 family members with myogenic regulatory factors following acute damaging muscle-lengthening contractions in humans. J Physiol 586: 5549-5560.
37. Apel PJ, Ma J, Callahan M, et al. 2010. Effect of locally delivered IGF-1 on nerve regeneration during aging: an experimental study in rats. Muscle Nerve 41: 335-341.
38. Meiri KF, Pfenninger KH, Willard MB., 1986. Growth-associated protein, GAP-43, a polypeptide that is induced when neurons extend axons, is a component of growth cones and corresponds to pp46, a major polypeptide of a subcellular fraction enriched in growth cones. Proc Natl Acad Sci USA 83: 3537-3541.
39. Benowitz LI, Routtenberg A., 1997. GAP-43: an intrinsic determinant of neuronal development and plasticity. Trends Neurosci 20: 84-91.
40. Aigner L, Arber S, Kapfhammer JP, et al. 1995. Overexpression of the neural growth-associated protein GAP-43 induces nerve sprouting in the adult nervous system of transgenic mice. Cell 83: 269-278.
41. Kues WA, Sakmann B, Witzemann V., 1995. Differential expression patterns of five acetylcholine receptor subunit genes in rat muscle during development. Eur J Neurosci 7: 1376-1385.
42. Hall ZW, Sanes JR., 1993. Synaptic structure and development: the neuromuscular junction. Cell 72: 99-121.
43. Shen J, Ma J, Elsaidi GA, et al. 2005. Gene expression of myogenic regulatory factors following intramuscular injection of botulinum A toxin in juvenile rats. Neurosci Lett 381: 207-210.
44. Sabourin LA, Rudnicki MA., 2000. The molecular regulation of myogenesis. Clin Genet 57: 16-25.
45. Charbonnier F, Della Gaspara B, Armand AS, et al. 2003. Specific activation of the acetylcholine receptor subunit genes by MyoD family proteins. J Biol Chem 278: 33169-33174.
46. Piette J, Bessereau JL, Huchet M, et al. 1990. Two adjacent MyoD1-binding sites regulate expression of the acetylcholine receptor alpha-subunit gene. Nature 345: 353-355.
47. Liu Y, Sugiura Y, Padgett D, et al. 2010. Postsynaptic development of the neuromuscular junction in mice lacking the gamma-subunit of muscle nicotinic acetylcholine receptor. J Mol Neurosci 40: 21-26.